A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships-Reference-Cited by-同舟云学术

A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships

Published:2023-02 Issue: Volume:210 Page:105495
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Goethals Olivia,Voge Natalia V.,Kesteleyn Bart,Chaltin Patrick,Jinks Tim,De Marez Tine,Koul Anil,Draghia-Akli Ruxandra,Neyts Johan,Van Loock Marnix

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference46 articles.

1. Safety, tolerability and pharmacokinetics of a novel pan-serotyp dengue antiviral small molecule in a phase 1, double-blind, randomized, dose-escalation study;Ackaert,2021

2. The impact of the priority review voucher on research and development for tropical diseases;Aerts;Pharmaceut. Med.,2022

3. Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature;Aerts;Health Pol.,2017

4. The status of neglected tropical diseases amidst covid-19 in africa: current evidence and recommendations;Akinokun;Health Promot. Perspect.,2021

5. Neglected Tropical Diseases;Bill,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative advances for neglected tropical disease (NTD): A global perspective from intellectual property;Technology in Society;2024-09

2. Dengue virus: pathogenesis and potential for small molecule inhibitors;Bioscience Reports;2024-08

3. Antiviral drug discovery: Pyrimidine entry inhibitors for Zika and dengue viruses;European Journal of Medicinal Chemistry;2024-06

4. Dengue, Zika, chikungunya : un état des lieux en France hexagonale;Médecine et Maladies Infectieuses Formation;2024-06

5. A scientific career from the early 1960s till 2023: A tale of the various protagonists;Biochemical Pharmacology;2024-05